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HIV‑exposed uninfected infants: elevated
cord blood Interleukin 8 (IL‑8) is significantly
associated with maternal HIV infection
and systemic IL‑8 in a Kenyan cohort
Barbara Lohman‑Payne1* , Benjamin Gabriel1, Sangshin Park2,3, Dalton Wamalwa4,
Elizabeth Maleche‑Obimbo4, Carey Farquhar5,6,7, Rose Kerubo Bosire8,9 and Grace John‑Stewart5,6,7,10

Abstract
Background: In low and middle income countries, human immunodeficiency virus (HIV) exposed, uninfected
(HEU) infants demonstrate higher morbidity and mortality than their unexposed counterparts. To determine possible
immune correlates of this effect, we investigated the impact of in utero HIV exposure on the uninfected neonatal
immune milieu and maternal factors mediating these abnormalities in a cohort of vaginally delivered mother-infants.
Samples of delivery and cord blood plasma were selected from 22 Kenyan HIV-infected women and their HIV exposed
uninfected (HEU) infants drawn from the pre-ARV era, while 19 Kenyan HIV-uninfected (HU) women and their infants
were selected from a control cohort.
Results: Compared to HU cord plasma, HEU cord plasma contained significantly higher levels of pro-inflammatory
cytokines interleukins (IL)-6 and -8 (both p < 0.001) and significantly lower levels of CXC motif chemokine 11 (CXC11)
(p < 0.001). Mediation analysis demonstrated that maternal HIV infection status was a significant determinant of infant
IL-8 responses: HEU status was associated with a ninefold higher infant:mother (cord:delivery) plasma levels of IL-8
(p < 0.005), whereas maternal viral load was negatively associated with HEU IL-8 levels (p = 0.04) and not associated
with HEU IL-6 levels.
Conclusions: Exposure to maternal HIV infection drives an increase in prenatal IL-8 that is partially mediated by
maternal cytokine levels. Differences between maternal and infant cytokine levels strongly suggest independent
modulation in utero, consistent with prenatal immune activation. Elevated pro-inflammatory signals at birth may
interfere with T cell responses at birth and subsequently influence immune maturation and the risk of morbidity and
mortality in HEU infants.
Keywords: HEU, IL-8/CXCL8, MIP-1α, MIP-1β, IL-6, MIP-3α, GM-CSF, IL-10, CXCL11, Viral load, In utero HIV exposure,
Structural equation models
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Background
Successful implementation of global programs for the
prevention of mother-to-child transmission (PMTCT)
of HIV has decreased perinatal HIV infections from
500,000 to 15,000 cases per year worldwide in the last
decade (UNAIDS, 2015). However, it is now evident that
this has created a large and expanding number of HIV
exposed but uninfected (HEU) infants. These infants
experience increased rates of morbidity and mortality
compared with their HIV unexposed (HU) counterparts.
A recent meta analysis of 22 studies from low and middle income countries showed a 70% increase in mortality
among HEU during the first 2 years of life, and several
individual studies report a 3- to fourfold increase in mortality over HU [1, 2].
The preponderance of current evidence suggests that
the immune systems of HEU children differ in fundamental ways from HU children including changes in the numbers and proportions of leukocyte subsets present from
the first months of life [3–5]. At birth cord blood T cells
from HEU children can mount HIV-1 specific responses,
indicating exposure to circulating maternal HIV antigen
[6, 7]. In response to a range of stimuli, HEU cord blood
mononuclear cells (CBMC) produce different cytokine
profiles and reduced T cell helper responses compared
to HU CBMC [8, 9]. However, there is controversy in the
field as to the cause of the observed immune changes in
HEU infants, the relative contribution of maternal health,
and relative differences observed in HIV unexposed
infants from the same communities. It is plausible that
chronic in utero exposure to the maternal environment
of persistent HIV infection affects the developing neonatal immune system, resulting in the immune alterations
observed at birth. Equally plausible is that exposure to
antiretroviral medications, poor nutrition, or exposure to
multiple environmental antigens other than HIV, could
stimulate a similar profile in HIV unexposed infants living in similar conditions.
Here we designed a retrospective study using careful
specimen selection to systematically minimize the above
factors known or suspected to confound interpretation
of HEU data. Specifically we drew from specimen and
data archives established prior to ARV interventions and
purposefully selected mother-infants pairs with a clinical medical record indicating no infections or hospitalizations during the study duration in order to minimize
the effects of environmental pathogens. Moreover we
selected HEU infants and HU control infants of similar
birthweight and gestational age and chose to evaluate
infant cord blood as a window into prenatal immunity.
Here we demonstrate cord blood plasma T cell cytokines
and chemokines from HIV uninfected infants born
to HIV infected women not taking ARV are markedly
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different from HIV unexposed infants. HIV positive
maternal T cell cytokines were markedly lower than HIV
uninfected women at delivery, and despite this, HEU
cord plasma contained significantly elevated levels of the
pro-inflammatory and chemotactic cytokines IL-6 and
IL-8 and reduced levels of an interferon gamma (IFN-γ)induced chemokine, CXCL11 compared to HU infants.

Methods
Cohort and specimen selection

This study used specimens from two cohort studies.
Cohort 1 was a randomized controlled trial conducted
1992–1998 in Nairobi, Kenya prior to the availability of
antiretrovirals for prevention of mother-to-child-transmission, as previously described [10]. HIV seropositive
women were enrolled during pregnancy, and provided
written informed consent for participation in the study
and storage of specimens. Maternal peripheral blood
was collected when women presented at the hospital at
onset of delivery. Maternal plasma HIV-1 RNA levels at
delivery were determined using a transcription-mediated
amplification (TMA) method sensitive for the detection
of multiple HIV subtypes (Gen-probe HIV-1 viral load
assay) [11]. We selected samples from the HIV infected
cohort based on proportional representation across quartiles of maternal HIV viral load, as a surrogate for levels
of fetal exposure to HIV. Infants were examined and cord
blood was collected at birth. Infants were tested quarterly
for HIV-1 using HIV-1 PCR filter paper assays [12]. All
infants selected for the current study were HIV-1 antibody negative at 24 months of age.
Cohort 2 enrolled HIV uninfected women between
2004 and 2006, as previously described [13]. The infection
status of women enrolled in the HIV uninfected cohort
was verified by two HIV-1 rapid tests (determine HIV-1/
HIV-2 antibody/HIV-1 antigen test, Abbott Laboratories,
Abbott Park, IL and Unigold HIV-1 antibody test, Trinity Biotech, Bray, Ireland). Women were recruited during
pregnancy and provided written informed consent for
participation and storage of specimens. Maternal peripheral blood was collected at delivery and infants were
examined and cord blood collected at birth.
Women/infant pairs from both cohorts were selected to
reduce factors suspected of influencing infant immunity:
lack of history of sexually transmitted infection (STI), not
currently receiving treatment for an STI, HIV uninfected
singleton infant, normal birth-weight > 2500 g, and normal gestational age > 37 weeks, as defined in the parent
study [10]. All specimen collection was conducted within
the guidelines of the Declaration of Helsinki and all components of this study were approved by the Kenyatta
National Hospital Ethics and Research Committee and
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the Institutional Review Boards (IRB) of the University of
Washington and the University of Rhode Island.
Detection of plasma cytokines

Peripheral and cord blood plasma was separated from
EDTA-anticoagulated blood at the time of delivery and
stored frozen at − 80 °C. We analyzed duplicate plasma
samples for levels of interleukins (IL)-1β, IL-2, IL-4,
IL-5, IL-6, IL-7, IL-8 (also known as CXCL8), IL-10,
IL-12(p70), IL-13, IL-17A, IL-21 and IL-23, interferon
(IFN)-γ, tumor necrosis factor (TNF)-α, granulocyte/
macrophage-colony stimulatory factor (GM-CSF), as
well as chemokines CCL3, CCL4, CCL20, CXCL11
and CX3CL1 using a multiplexed high sensitivity
human T-cell cytokine magnetic bead panel (EMD Millipore Corp., Billerica, MA, USA). Three independent plates were run with standard- and plate-controls;
women-infant pairs were grouped per plate. Assays
were conducted in accordance with the manufacturer’s
instructions. All cytokine values below the lower limit of
detection were recoded as the lower limit of detection of
individual cytokine standards.
Statistical analysis

Cytokine data were tested for outliers and reported as
medians and interquartile ranges. Medians of related
samples were compared using Wilcoxon rank sum test
and independent sample medians were compared using
Mann–Whitney U. The cohort size for paired samples
of HIV-infected women at delivery and their infant cord
blood was 22, while the cohort size for HIV uninfected
women at delivery and their infant cord blood was 19. In
unpaired analyses, data from an additional 8 HEU cord
blood specimens were included. Linear regression was
used for analysis of cord blood IL-8 and viral load. Bonferroni correction for multiple comparisons was applied
to multiplexed cytokine data.
Mediation analyses using structural equation modeling
(SEM) [14, 15] were conducted to determine whether all,
or part, of the relationship between maternal HIV status
(infected/uninfected) and cord blood cytokine levels was
explained by maternal cytokine levels. Mediation analyses were also performed to determine whether maternal cytokine levels mediated the relationship between
maternal viral load and infant cord blood cytokines. Data
were natural log transformed for mediation analysis. Statistical analyses were performed using Prism (version
6.0f, GraphPad, La Jolla, CA) and SAS 9.4 software (SAS
Institute, Cary, NC). A p value < 0.05 was considered to
be statistically significant, unless corrected for multiple
comparisons.
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Results
Cohort description

The HIV-1-infected women selected for this sub-study
were representative of the original HIV cohort as young,
moderately immunosuppressed, without a medical history of HIV-related illnesses. Specifically, the median
age at enrolment was 25 years (interquartile range (IQR),
23–28). The women had a median CD4+ T cell count of
403 cells/ml (IQR, 313–523) and CD4:CD8 ratio of 0.44
(IQR, 0.29–0.73). Nineteen percent of the HIV positive women had a CD4:CD8 ratio greater than 1.0. The
median viral load at delivery was 4.6 log10 RNA copies/
ml plasma (IQR, 4.4–5.1). The HIV uninfected motherinfant cohort was enrolled from a similar community.
The median age at enrolment was 25 years (IQR, 23–29).
Infants born to HIV infected and HIV uninfected groups
of women were of similar birth-weight: 3.3 kg (IQR, 3.0–
3.6) vs 3.1 kg (IQR 2.9–3.5), respectively.
HIV‑infected women have increased IL‑8 at delivery
compared to HIV‑uninfected women

The infant’s nascent leukocyte responses occur in the
presence of ‘pre-conditioned’ prenatal cytokine milieu,
based on maternal–fetal exposures. We chose to evaluate
maternal delivery specimens as a reflection of prenatal
and early life exposures. All pregnant women regardless of HIV status presented at delivery with detectable
pregnancy-supporting cytokines IL-4 and -10, although
the HIV-infected women had significantly lower levels of
IL-4 (14 pg/ml (IQR, 8–19) vs 136 pg/ml (IQR, 84–164)
and IL-10 (5 pg/ml (IQR, 4–9 vs 19 pg/ml IQR, 8–23,
p < 0.001, respectively), compared to HIV-uninfected
women (Table 1).
Unsurprising for a population of women with chronic
untreated HIV and a median CD4 of ~ 400 cells/ml, the
HIV-infected women had significantly lower levels of 14
of the 21 T cells cytokines across the broad range of functions including pro-inflammatory, chemotactic, immunoregulatory, and Th2 type cytokines compared to HIV
uninfected women. Interestingly, IL-8 was detected at a
significantly higher level compared to HIV-uninfected
women; HIV-infected women had a fourfold increase in
levels of plasma cytokine IL-8 at delivery compared to
uninfected women (36 pg/ml (IQR 15–361) vs 9 pg/ml
(IQR 8–13) p < 0.001, respectively).
Infants differing by HIV exposure status in utero: HEU
infants are born with significantly increased levels of IL‑6
and ‑8 and decreased levels of CXCL11 compared to HU
infants

Of 21 T cell cytokines/chemokines measured, 15 were
present at median concentrations above the lowest limit
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Table 1 Maternal plasma mediators at delivery from HIV-uninfected and HIV-infected women
Mediator, pg/ml

LLD

HIV uninfected na = 19

HIV infected n = 22

53 (29–103)

Median (IQR)

p valueb

Median (IQR)

Pro-inflammatory
IL-23

8.0

194 (151–408)

IL-17α

0.7

7 (5–12)

2 (1–4)

< 0.001
< 0.001

IL-12(p70)

0.5

5 (4–8)

2 (1–2)

< 0.001

TNF-α

0.4

8 (7–10)

6 (5–7)

< 0.001

IL-1β

0.5

5 (5–7)

2 (1–5)

0.25

IL-6

0.2

9 (6–30)

6 (2–40)

0.25

Chemotactic
IL-8/CXCL8

0.3

9 (8–13)

36 (15–361)

< 0.001

CX3CL1

18.0

333 (205–459)

71 (48–120)

< 0.001

CCL20

0.6

22 (19–27)

15 (13–20)

< 0.002

CXCL11

1.5

157 (93–236)

45 (24–85)

< 0.001

CCL3

0.3

30 (25–34)

13 (10–57)

0.25

CCL4

1.0

33 (27–46)

13 (7–56)

0.02

Immunoregulatory
IFN-γ

0.6

21 (17–32)

12 (11–17)

< 0.001

IL-7

0.4

14 (10–18)

7 (5–10)

< 0.001

IL-2

0.5

0 (0–5)

2 (1–3)

0.09

IL-21

0.3

3 (1–5)

2 (1–4)

1.0

IL-4

1.8

136 (84–162)

14 (8-19)

< 0.001

IL-5

0.5

4 (2–5)

2 (1-2)

< 0.001

Th2

IL-10

1.5

GM-CSF

1.2

IL-13

0.3

19 (8–23)
282 (132–358)
10 (5–16)

5 (4-9)

< 0.001

37 (21-51)

< 0.001

5 (4-8)

0.01

Bonferroni correction for multiple comparisons was applied; thus p < 0.003 was considered significant
LLD lower limit of test kit detection, pg/ml
a

Number women with plasma samples available at time of delivery

b

Independent sample medians were compared using Mann–Whitney U test

of detection (Table 2). Pro-inflammatory cytokines IL-6
and -23 were significantly different in HEU vs HU cord
blood samples. Median IL-6 levels were ~ 25-fold higher
in HEU infants compared to HU infants (24 pg/ml (IQR
2–155), vs 1 pg/ml (IQR 1–6), respectively). Levels of
IL-23 were undetectable in the HEU infant cord blood;
a subset of HU infant cord blood samples had detectable
levels sufficient for the group medians to be significantly
different (p < 0.001). Chemotactic cytokines IL-8 and
CXCL11 were significantly different in cord blood plasma
from infants exposed to HIV in utero (both p < 0.001).
Median cord blood plasma IL-8 levels were > 50-fold
higher in HEU infants compared to HU infants.
(748 pg/ml (IQR, 93–1882) vs. 13 pg/ml (IQR 7–26),
respectively). CXCL11 was present at
significantly lower levels in HEU cord blood plasma
compared to HU cord plasma (p < 0.001). CXCL11, also

known as Interferon-inducible T-cell alpha chemotactic (ITAC) and Interferon-γ-inducible protein 9 (IP9),
was present at approximately half the levels found in
HU infants (154 pg/ml (IQR 65–254) vs 372 pg/ml (IQR
279–428)), while well above the lower limit of detection of 1.5 pg/ml). Immunoregulatory cytokine IL-21
and Th2 cytokine IL-5 levels were significantly different in cord blood plasma from HEU infants compared
to HU infants although of note many individual’s IL-21
and IL-5 cord blood levels were at or near the limit of
detection. The remaining cytokines tested were not
significantly different between HEU and HU (IL-7,
CX3CL1, CCL3, GM-CSF, IL-10, CCL20, IL-1β, CCL4,
TNF-α) or were below the lower limit of detection in
both populations (IFNγ, IL-12(p70), IL-13, IL-17α, IL-2
and IL-4).
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Table 2 Infant cord blood plasma mediators from HIV-Unexposed infants compared to HIV-exposed uninfected infants
Mediator, pg/ml

LLD

HIV unexposed (HU)

HIV exposed uninfected (HEU)

na

na

Median (IQR)

Median (IQR)

pb

Pro-inflammatory
IL-6

0.2

17

1 (1–6)

29

24 (2–155)

0.001

IL-23

8.0

16

8 (8–16)

30

8 (8–8)

0.001

IL-1β

0.5

18

4 (1–39)

28

TNF-α

0.4

19

18 (15–26)

30

7 (0.5–102)
15 (9–38)

0.800
0.300

Chemotactic
IL-8/CXCL8

0.3

19

CXCL11

1.5

19

13 (7–26)
372 (279–428)

29

748 (93–1882)

< 0.001

30

154 (65–254)

< 0.0001

CCL3

0.3

19

34 (17–70)

30

176 (29–1901)

0.030

CCL4

1.0

19

67 (61–121)

22

71 (290–152)

0.600

CCL20

0.6

19

40 (27–57)

26

47 (32–133)

0.100

CX3CL1

18.0

17

18 (18–28)

30

18 (18–18)

0.006

Immunoregulatory
IL-21

0.2

15

0.2 (0.2–0.2)

30

0.7 (0.3–2.2)

0.001

IL-7

0.4

19

6 (2–13)

30

2 (0.4–4)

0.003
< 0.0001

Th2
IL-5

0.5

17

0.6 (0.5–0.9)

30

0.5 (0.5–0.5)

IL-10

1.5

16

1.5 (1.5–7)

29

3 (1.5–6)

0.100

GM-CSF

1.2

19

7 (3–13)

30

5 (1.2–17)

0.700

The following cytokines were below the assay limit of detection in both populations: IFNγ, IL-12(p70), IL-13, IL-17α, IL-2 and IL-4
LLD lower limit of test kit detection, pg/ml
a

Number samples with valid results

b

Bonferroni correction for multiple comparisons was applied; p < 0.003 was considered significant

Cord blood plasma IL‑8 and CXCL11 levels are increased
compared to maternal delivery plasma

We conducted paired analyses of cytokine levels present in cord plasma relative to levels in maternal
plasma collected at delivery for the 23 HEU and 19
HU mother-infant dyads (Fig. 1). Median (IQR) HEU
cord blood IL-8 concentration was significantly higher
than that measured in maternal delivery blood plasma
(748 pg/ml, (IQR 93–1882) vs 36 pg/ml (IQR 15–361);
p < 0.001), suggestive of synthesis within the infant
circulation rather than passive transfer across the placenta. Median (IQR) HEU cord IL-6 levels were not
significantly higher than HIV + maternal blood plasma
levels (24 pg/ml (IQR 2–155) vs 6 pg/ml (IQR 2–40),
p = 0.019), while HU infants had lower cord blood IL-6
concentrations than their HIV uninfected mothers
(1 pg/ml (IQR 1–6) vs 9 pg/ml (IQR 6–30), p = 0.001).
Similarly, median (IQR) HEU cord IL-21 was lower and
levels did not reach significance when compared to
paired maternal delivery samples (0.7 pg/ml (0.4–2.2)
vs 2.0 pg/ml (1.1–3.6); p = 0.014). A different pattern
was observed for Th2 cytokine IL-5, which was largely
undetectable in cord blood plasma collected from
HEU infants and present at significantly lower levels

compared with cord blood from HU infants (0.5 pg/ml,
(0.5–0.5) vs (0.6 pg/ml (0.5–0.9), respectively).
The lower levels of CXCL11 and IL-23 observed in
HEU relative to HU cord blood plasma were not due
to lower maternal levels at delivery. Similar to our
observation with IL-8, median (IQR) HEU cord blood
levels of CXCL11 were significantly higher than maternal delivery blood plasma (153 pg/ml (IQR 65–254) vs
45 pg/ml (IQR 24–85) p < 0.001). In contrast, all individual HEU cord blood levels of IL-23 were below the limit
of detection, while readily detectable in HIV + maternal
plasma (53 pg/ml, (IQR 29–103). The data demonstrate
cord blood mediators are not uniformly concentrated
or diluted in infant cord blood, supporting a biologic
mechanism mediating the observed difference in HEU
cord blood as compared to a change in maternal–fetal
vascular permeability.
HIV exposure significantly alters pro‑inflammatory
cytokines present in cord blood compared to delivery
blood

The process of delivery is dynamic and to reflect the
physiologic range that exists for cytokines present in
maternal and infant circulations at delivery and birth
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we determined a group median index from individual
mother-infant pairs. An index > 1 indicates the cytokine
level in cord blood exceeds the level measured in the
infant’s mother’s delivery plasma.
HIV uninfected women and their unexposed infants
tended to have an index at or < 1 meaning maternal
cytokines levels in blood at delivery were greater or equal
to cord blood levels for IL-6, IL-8, IL-10, CCL3, GM-CSF,
IL-1β, CCL20 and IL-7 (Fig. 2). HEU cord blood/delivery cytokine indices were significantly greater than HU
indices for 7 of 11 detectable cytokines: IL-6, IL-8, IL-10,
CCL3, GM-CSF, CCL20, and CCL4 (closed vs open circles, p < 0.005). Several cytokines levels were not significantly different in cord blood relative to delivery blood
in HIV-infected women/HEU infants compared to HIVuninfected women and their HU infants: IL-1β, IL-7,
TNFα, and CXCL11.
Maternal HIV infection, but not viral load, drives infant
cord blood IL‑8 levels

Statistical modeling with structural equation mediation (SEM) is a powerful statistical approach to address
interdependent relationships among multiple variables
simultaneously and allows delineation of the relative
importance of factors within the direct causal pathway
on the outcome of interest [14, 15]. SEM was used to
estimate the effect of maternal HIV infection working through maternal cytokine levels on infant cord
blood cytokine levels. Maternal HIV infection status
had a large significant total combined effect on both
infant cord blood IL-6 and -8 levels (p < 0.001, Fig. 3).
Maternal HIV infection did not mediate its effect on
cord blood IL-6 through maternal plasma IL-6 levels
(p = 0.8), indicating maternal HIV infection affects
levels of infant cord blood IL-6 through pathways
not measured in this study (Fig. 3a). However, maternal plasma IL-8 levels contributed 23% of cord blood
IL-8 levels, a substantial percent for complex biological systems, while maternal HIV infection itself mediated 77% of the IL-8 present in cord blood through
unmeasured pathways (Fig. 3b). Maternal HIV status
had a significant but very small effect on cord blood
IL-21; this cytokine was not included in subsequent
models (total effect β = 0.02, p = 0.002).
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We hypothesized maternal viral load as a proxy for
stimulation of prenatal pro-inflammatory cytokines
directly. As shown in Fig. 4, the level of cord blood
plasma IL-8 was negatively correlated with maternal viral load with a low correlation coefficient and a
marginal p value (slope = − 0.006, r2 = 0.14, p = 0.04).
Additionally, SEM with maternal viral load and IL-8 in
the pathway for mediation of infant cord blood IL-8,
revealed no significant effect of maternal viral load.
Taken together these data do not support the hypothesis that maternal viral load directly stimulates infant
IL-8 production; alternatively, the negative slope, weak
r2 value and lack of significance in the SEM models
indicate factors beyond viral load explain the pattern
of HEU IL-8 levels at birth.

Discussion
We hypothesized that maternal HIV, either directly via
viral load/viral antigens or indirectly via altered plasma
cytokines, would set a different immune stage for HEU
infants than for HU infants. IL-6 and IL-8 levels present
in cord blood of HEU infants were significantly elevated
compared both to their HIV-infected mothers and to
their HIV-unexposed community peers. Our study provides a direct link between maternal HIV infection and
elevated levels of prenatal IL-6 and IL-8 measured in cord
blood from infants who were born HIV uninfected and
who did not acquire HIV through vaginal delivery and
breastfeeding during the first year of life and who were
unexposed to ARV. Our models demonstrate maternal
IL-8 directly mediated ~ 25% of the effect of HIV infection on cord blood IL-8, with ~ 75% of the effect unmeasured in this study, indicative of alternative pathways or
cellular sources of neonatal IL-8 induction and regulation. In contrast, maternal HIV infection did not mediate infant IL-6 levels via maternal IL-6, leaving all of the
effect of maternal HIV infection on neonatal IL-6 induction unexplained in our models.
We have extended the finding that IL-8 is not limited
to placental transfer in healthy women to that of HIVinfected-HEU mother-infant pairs [16, 17]. IL-8 is a
major T cell effector in newborns and can be produced
by endothelial cells, tissue macrophages, and cells of
monocytic origin [18]. The IL-8 detected in cord blood
here is plausibly derived from maternal or infant origin:

(See figure on next page.)
Fig. 1 HIV exposed uninfected infant cord blood displays elevated cytokines consistent with inflammation and immune stimulation compared
to HIV unexposed infant cord blood. Cytokines were detected in samples from all maternal delivery plasma and infant cord blood plasma using
multiplexed Luminex Elisa bead-based technology. Assays at or below the lower limit of detection were assigned the lowest limit of detection.
Individual plasma concentration (ln pg/ml), group median and IQR are plotted. Related sample medians (HEU vs HIV+ mother, n = 23 pairs; HU vs
HIV− mother, n = 19 pairs) were compared using Wilcoxon Rank Sum test while independent medians were compared using Mann–Whitney U test
(HEU vs HU). Symbols are as follows: HIV− women filled squares, HU infants open squares, HEU infants open circles, HIV+ women filled circles
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Fig. 2 HIV infection associated with changes in delivery and birth cytokine patterns. Cytokines were detected in samples from all maternal delivery
plasma and infant cord blood plasma using multiplexed Luminex Elisa bead-based technology and grouped by broad category. Assays at or
below the lower limit of detection were assigned the lowest limit of detection. Cytokines undetectable in the majority of HEU or HU samples were
not included: IL-5, IL-21, IL-23 and CX3CL1. The ratio of infant cord blood to maternal delivery blood plasma cytokine levels was calculated. Each
cytokine ratio is plotted for HU infant-HIV negative mother (open circles) and HEU infant-HIV-infected mother (closed circles) and the fold change
from the HU group median is indicated. Independent group medians were compared using Mann–Whitney U test with correction for multiple
comparisons p < 0.005. Significant mediators are bolded

Fig. 3 Maternal HIV infection drives infant IL-6 and IL-8 levels present at birth in HEU infants through different pathways. SEM models with maternal
HIV infection (yes/no), maternal IL-8 levels at delivery in the pathway, and infant cord blood IL-8 levels as the outcome variable for 42 mother-infant
pairs. HEU infants have 2.38 ln IL-6 levels in cord blood at birth and none of the infant IL-6 is attributable to maternal IL-6 levels (a). HEU infants have
3.75 times ln IL-8 levels in cord blood than detected in HU cord blood, and ~ 23% of this can be attributed to the maternal IL-8 levels (b)
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Fig. 4 Linear regression of HEU infant cord blood IL-8 levels by
maternal HIV at delivery. The impact of maternal HIV RNA copies/
ml plasma on HEU plasma IL-8 concentrations was determined
using linear regression. HIV RNA copies were determined using TMA
method; IL-8 levels were determined using multiplexed ELISA format,
both as described in methods. A negative linear association between
maternal viral load and infant IL-8 concentrations at birth is shown by
the dashed line, slope = − 0.0055

from viral antigen-stimulated endothelial cells lining the
umbilical cord, tissue macrophages present in the syncytiotrophoblast layer of the placenta or monocytic cells of
infant ontogeny [19].
The onset of active labor and vaginal delivery is associated with elevated levels of IL-6 in both maternal and
infant circulation [20], however we recorded a ~ 50-fold
increase in the IL-6 index of cord blood to delivery blood
observed in HEU compared to HU mother-infant pairs,
the biggest difference amongst the mediators measured. Infection and inflammation during pregnancy are
hypothesized to be associated with induction of placental
cytokines, including IL-6, and increased fetal exposure to
pro-inflammatory cytokines can result in increased risk
of infant neurologic injury, even in the absence of HIV
[21]. In addition to maternal infection/inflammation,
direct transfer of microbes secondary to HIV infection
may occur from the maternal bloodstream across the placenta into the fetal circulation, such as has been observed
with increased gut microbial translocation [22]. Alternatively direct or indirect microbial LPS stimulation may
induce placental cytokine production and the release or
production of downstream mediators following Toll-like
receptor signalling [23].
The elevated levels of IL-8 we observed in HEU but
not in HU cord blood could result from a combination
of increased production or decreased down-regulation of
IL-8. As part of the pro-inflammatory antiviral immune
response, intracellular regulators of IL-8 include IFN-γ, a
cytokine notably present at low levels in newborns [24,
25]. Thus newborns with low levels of IFN-γ might be
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unable to down-regulate IL-8. Additionally, HIV tat has
been shown to signal production of IL-8 [26], and ongoing genital tract viral replication during pregnancy could
result in placental HIV tat. Prolonged exposure of fetal
and neonatal T lymphocytes to elevated IL-8 likely leads
to intracellular signaling of gene pathways associated
with cell survival, proliferation, and metabolism [27].
Hypothetically, neutrophils and other granulocytes programmed to respond to IL-8 along a chemotactic gradient also might be unable to respond to the signals if there
is no functional gradient present, disabling the intended
effect of chemotaxis and instead resulting in an immune
‘confusion’ or ‘paralysis’ until levels of circulating IL-8/
IL-6 return to homeostasis. The consequence of a lack of
recruitment of neutrophils to the sites of tissue damage
and infection is consistent with clinical descriptions of
HEU morbidity and mortality.
Our analyses demonstrated a consistent pattern of significantly increased levels of chemotactic cytokines present in cord blood compared to delivery blood in HEU
infants compared to HU infants (Fig. 2). The increased
relative concentrations of IL-8, CCL3, CCL4, CCL20 in
HEU circulation compared to maternal circulation suggests a coordinated response to inflammatory signaling.
GM-CSF, although present at levels below that found in
maternal circulation, is significantly increased in HEU
compared to HU infants. IL-10 levels are increased in
HEU infants, although still lower than levels found in
maternal circulation. IL-10 is in part regulated by IL-6
levels, thus it is feasible higher circulating IL-6 levels release the inhibition on IL-10 production in HEU
infants. Regardless the source of mediators detected
in HEU cord blood, the finding of significantly elevated
cytokines compared to both HIV unexposed control cord
blood plasma as well as paired maternal blood collected
at delivery suggests controlled HIV infection during
pregnancy drives the fetal immune response.
This study had several strengths. Access to stored
specimens from the pre-ARV era allowed us to eliminate the direct and indirect effect of ARVs on maternal
and neonatal cytokine production. Longitudinal HIV
testing within the parent cohorts allows us to rule out
individuals with subsequent acquisition of HIV. While
the inclusion of Kenyan HIV-uninfected mother-infant
dyads is a strength of the study, allowing us to examine
cytokine responses in populations of women living in
similar socio-economic conditions, it raises a potential
weakness considering the time difference in collection
of samples from the two cohorts. Further research is
needed to determine the cellular source of the elevated
IL-8 and the mechanism of induction/or release from
negative feedback for production of this cytokines.
Additionally, because we selected normal birthweight
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and gestational age infants for both HEU and HU
infants, we cannot assess the role of maternal and fetal
systemic inflammation on birth anthropometry.
The majority of immune function studies of HEU
compared to HU infants have evaluated cellular
responsiveness following antigenic stimulation in vitro.
Our studies focused on the prenatal cytokine environment in which presumably the cellular response would
arise. In a study of plasma cytokines from HEU and HU
infants born to HIV+ ARV-treated and healthy HIV−
pregnant Brazilian women, HEU and HU cord blood
plasma IL-8 levels were low and similar in HEU infants
delivered via Caesarian section compared to HU infants
delivered vaginally [28]. It remains an important public
health goal to identify the effects of chronic maternal
infections on fetal and infant immunity, correlations
with infant health, and response to maternal antiviral
treatments.

Conclusions
We conclude that in utero stimuli stemming from
infection generated an immune profile consistent with
fetal/infant immune activation, particularly cytokines
associated with macrophage activation, above what
is expected at parturition. The weak association with
maternal viral load raises the concern that HEU infants
exposed to ARV may still be at risk for increased altered
immune profile at birth.
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